| 标题 |
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual disease |
| 网址 | |
| DOI | |
| 其它 |
期刊:Future Oncology 作者:A. Saeed; G. Yothers; S. Puhalla; Alireza Tojjari; P. Rastogi; et al 出版日期:2026-06-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)